THE EFFECTS OF UPADACITINIB ON ULCERATIVE COLITIS SYMPTOM RESOLUTION AND FATIGUE NORMALIZATION IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: PHASE 3 U-ACHIEVE AND U-ACCOMPLISH RESULTS

被引：0
|
作者：
D'Haens, Geert
Tran, Jacinda N.
Danese, Silvio
Rubin, David T.
Aoyama, Nobuo
Lugering, Andreas
Klaff, Justin
Xuan, Si
Ilo, Dapo
Gonzalez, Yuri Sanchez
Panes, Julian
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1737
引用
收藏
页码：S1102 / S1103
页数：2
相关论文
共 50 条
  • [1] Effects of upadacitinib on ulcerative colitis symptom resolution and fatigue normalization in patients with moderately to severely active ulcerative colitis: Phase 3 U-ACHIEVE and U-ACCOMPLISH results
    Pudipeddi, A.
    D'Haens, G.
    Tran, J.
    Danese, S.
    Rubin, D. T.
    Aoyama, N.
    Luegering, A.
    Klaff, J.
    Xuan, S.
    Ilo, D.
    Gonzalez, Y. Sanchez
    Panes, J.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 137 - 138
  • [2] The effects of upadacitinib on ulcerative colitis symptom resolution and fatigue normalization in patients with moderately to severely active ulcerative colitis: Phase 3 U-ACHIEVE and U-ACCOMPLISH results
    D'Haens, G.
    Tran, J.
    Danese, S.
    Rubin, D. T.
    Aoyama, N.
    Lugering, A.
    Klaff, J.
    Xuan, S.
    Ilo, D.
    Gonzalez, Y. Sanchez
    Panes, J.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : I27 - I29
  • [3] Upadacitinib was not associated with anaemia in patients with moderately to severely active ulcerative colitis: Results from the U-ACHIEVE study
    D'Haens, G.
    Hebuterne, X.
    Higgins, P. D. R.
    Loftus, E. V., Jr.
    Zhou, W.
    Lacerda, A. P.
    Xie, W.
    Liu, J.
    Danese, S.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S580 - S581
  • [4] UPADACITINIB WAS NOT ASSOCIATED WITH ANAEMIA IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE U-ACHIEVE STUDY
    D'Haens, Geert R.
    Hebuterne, Xavier
    Higgins, Peter D.
    Loftus, Edward V.
    Zhou, Wen
    Lacerda, Ana P.
    Xie, Wangang
    Liu, Jianzhong
    Danese, Silvio
    GASTROENTEROLOGY, 2020, 158 (06) : S1205 - S1206
  • [5] Efficacy and Safety of Upadacitinib as Induction Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Results From Phase 3 U-ACCOMPLISH Study
    Vermeire, Severine
    Danese, Silvio
    Zhou, Wen
    Pangan, Aileen
    Greenbloom, Susan
    D'Haens, Geert
    Panes, Julian
    Juillerat, Pascal
    Lindsay, James
    Loftus, Edward V.
    Sandborn, William
    Reinisch, Walter
    Sanchez-Gonzalez, Yuri
    Huang, Bidan
    Xian, Wangang
    Liu, Jianzhong
    Weinreich, Michael
    Panaccione, Remo
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S357 - S357
  • [6] Efficacy and safety of upadacitinib as induction therapy in patients with Moderately to Severely Active Ulcerative Colitis: Results from phase 3 U-ACCOMPLISH study
    Vermeire, S.
    Danese, S.
    Zhou, W.
    Pangan, A.
    Greenbloom, S.
    D'Haens, G.
    Panes, J.
    Juillerat, P.
    Lindsay, J. O.
    Loftus, E. V., Jr.
    Sandborn, W. J.
    Reinisch, W.
    Gonzalez, Y. Sanchez
    Huang, B.
    Xie, W.
    Liu, J.
    Weinreich, M. A.
    Panaccione, R.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S021 - S022
  • [7] The effects of maintenance therapy with upadacitinib on abdominal pain, bowel urgency, and fatigue in patients with moderately to severely active Ulcerative Colitis: Phase 3 U-ACHIEVE maintenance results
    Danese, S.
    Tran, J.
    D'Haens, G.
    Rubin, D. T.
    Aoyama, N.
    Zhou, W.
    James, B.
    Yao, X.
    Gonzalez, Y. Sanchez
    Panaccione, R.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I008 - I009
  • [8] Efficacy and Safety of Upadacitinib Induction Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Results From the Phase 3 U-ACHIEVE Study
    Danese, Silvio
    Vermeire, Severine
    Zhou, Wen
    Pangan, Aileen
    Siffledeen, Jesse
    Hebuterne, Xavier
    Nakase, Hiroshi
    Chen, Minhu
    Higgins, Peter
    Sanchez-Gonzalez, Yuri
    Huang, Bidan
    Xian, Wangang
    Liu, Jianzhong
    Weinreich, Michael
    Panaccione, Remo
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S312 - S313
  • [9] Efficacy and safety of upadacitinib induction therapy in patients with Moderately to Severely Active Ulcerative Colitis: Results from the phase 3 U-ACHIEVE study
    Danese, S.
    Vermeire, S.
    Zhou, W.
    Pangan, A.
    Siffledeen, J.
    Hebuterne, X.
    Nakase, H.
    Higgins, P.
    Chen, M. H.
    Sanchez-Gonzalez, Y.
    Huang, B.
    Xie, W.
    Liu, J.
    Weinreich, M.
    Pannaccione, R.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S022 - S024
  • [10] Efficacy and Safety of Upadacitinib Maintenance Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Final Results From the Phase 3 U-ACHIEVE Maintenance Study
    Vermeire, Severine
    Danese, Silvio
    Zhou, Wen
    Yao, Xuan
    Ilo, Dapo
    Liu, John
    Hebuterne, Xavier
    Lindsay, James
    Sanchez-Gonzalez, Yuri
    Higgins, Peter D.
    Colombel, Jean-Frederic
    Panaccione, Remo
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S521 - S522
12345